Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Apyx Medical Corporation (APYX) had Cost of Goods Sold of $5.01M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$13.88M |
|
$-3.24M |
|
|
Cost of Goods Sold |
$5.01M |
$8.87M |
|
$15.69M |
|
$-1.81M |
|
$-1.14M |
|
$-2.95M |
|
$-2.95M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-1.81M |
|
$-1.61M |
|
43.85M |
|
43.85M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$53.16M |
|
$2.11M |
|
$7.92M |
|
$61.07M |
|
$9.35M |
|
$35.33M |
|
$40.63M |
|
$49.98M |
|
$11.09M |
|
$11.09M |
|
$11.09M |
|
42.12M |
|
| Cash Flow Statement Financials | |
$-4.06M |
|
$-0.13M |
|
$0.08M |
|
$31.74M |
|
$27.62M |
|
$-4.12M |
|
$1.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.68 |
|
-- |
|
-- |
|
0.76 |
|
3.19 |
|
63.89% |
|
-13.01% |
|
-13.01% |
|
-- |
|
-21.23% |
|
-23.36% |
|
$-4.19M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.47 |
|
1.02 |
|
88.25 |
|
-27.70% |
|
-27.70% |
|
-5.03% |
|
-6.62% |
|
$0.26 |
|
$-0.10 |
|
$-0.09 |
|